Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6291931rdf:typepubmed:Citationlld:pubmed
pubmed-article:6291931lifeskim:mentionsumls-concept:C0001497lld:lifeskim
pubmed-article:6291931lifeskim:mentionsumls-concept:C0917874lld:lifeskim
pubmed-article:6291931lifeskim:mentionsumls-concept:C0678594lld:lifeskim
pubmed-article:6291931lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:6291931pubmed:issue3lld:pubmed
pubmed-article:6291931pubmed:dateCreated1983-1-19lld:pubmed
pubmed-article:6291931pubmed:abstractTextHuman muscle adenylate kinase (ATP:AMP phosphotransferase, EC 2.7.4.3.) was studied by 1H-nuclear magnetic resonance spectroscopy. The C-2 and C-4 proton resonances of the active-center histidine His-36 could be identified; the pK of His-36 was determined as 6.1. The pK of His-189 is very low (4.9) although it is located at the surface of the protein. Other resonance lines are discussed in comparison with NMR spectra of porcine adenylate kinase [McDonald et al. (1975) J. Biol. Chem. 250, 6947-6954]. A pH-dependent structural isomerization as shown by X-ray crystallography in the pig enzyme [Pai et al. (1977) J. Mol. Biol. 114, 37-45] was not observed for human adenylate kinase in solution. However, the binding of adenosine(5')pentaphospho(5')adenosine (Ap5A), a bisubstrate inhibitor, to adenylate kinase causes an overall change of the NMR spectrum indicative of a large conformational change of the enzyme. The exchange rate (koff) for Ap5A was estimated as 10 s-1 and decreases by addition of Mg2+. On the basis of these values and the known dissociation constant it is likely that the binding of Ap5A is a diffusion-controlled process kon being 10(8) M-1 s-1. In conclusion, the system Ap5A/Mg2+/human adenylate kinase, which has been studied by NMR spectroscopy and X-ray diffraction in parallel, is suitable for analyzing the induced fit postulated by Jencks for all kinase-catalyzed reactions.lld:pubmed
pubmed-article:6291931pubmed:languageenglld:pubmed
pubmed-article:6291931pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291931pubmed:citationSubsetIMlld:pubmed
pubmed-article:6291931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291931pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6291931pubmed:statusMEDLINElld:pubmed
pubmed-article:6291931pubmed:monthSeplld:pubmed
pubmed-article:6291931pubmed:issn0014-2956lld:pubmed
pubmed-article:6291931pubmed:authorpubmed-author:SchirmerR HRHlld:pubmed
pubmed-article:6291931pubmed:authorpubmed-author:KalbitzerH...lld:pubmed
pubmed-article:6291931pubmed:authorpubmed-author:RöschPPlld:pubmed
pubmed-article:6291931pubmed:authorpubmed-author:MarquetantRRlld:pubmed
pubmed-article:6291931pubmed:issnTypePrintlld:pubmed
pubmed-article:6291931pubmed:day1lld:pubmed
pubmed-article:6291931pubmed:volume126lld:pubmed
pubmed-article:6291931pubmed:ownerNLMlld:pubmed
pubmed-article:6291931pubmed:authorsCompleteYlld:pubmed
pubmed-article:6291931pubmed:pagination531-6lld:pubmed
pubmed-article:6291931pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:meshHeadingpubmed-meshheading:6291931-...lld:pubmed
pubmed-article:6291931pubmed:year1982lld:pubmed
pubmed-article:6291931pubmed:articleTitleThe structural isomerisation of human-muscle adenylate kinase as studied by 1H-nuclear magnetic resonance.lld:pubmed
pubmed-article:6291931pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6291931pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6291931lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6291931lld:pubmed